Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014286 · ClinicalTrials.gov registry record
Lung Cancer Mutation Consortium Protocol
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 1,100
- Enrollment target
NCT01014286 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 1,100 participants.
The verdict
NCT01014286 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 1,100 participants
- Enrollment target
Study Summary
The primary objective of this protocol is to determine the frequency of oncogenic mutations in 1000 patients with advanced adenocarcinoma of the lung. The linked clinical and mutational analyses will be used to determine the frequency of each mutation, its association with clinical features and outcome, and its association with other mutations. As future therapeutic protocols specific for these mutations are developed, patients may be notified of their eligibility for these studies. Future translational studies may be used to: a) unravel the complex biology of lung cancer; b) identify prognostic markers; c) define predictive markers of response/resistance to new therapies; d) identify new targets. A secondary goal is to establish a consortium of sites that have the capability of conducting multiple mutation testing in a Clinical Laboratory Improvement Amendments (CLIA) certified lab.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2009-09-16 |
| Est. Completion | 2019-01-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014286
The ClinicalTrials.gov registry entry for NCT01014286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01014286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014286 about?
NCT01014286 is a clinical study titled "Lung Cancer Mutation Consortium Protocol". The primary objective of this protocol is to determine the frequency of oncogenic mutations in 1000 patients with advanced adenocarcinoma of the lung. The linked clinical and mutational analyses will be used to determine the frequency of each mutation, its association with clinical features and outc...
What is the current status of trial NCT01014286?
This trial is currently completed. The enrollment target is 1,100 participants. The study started on 2009-09-16. Estimated completion is 2019-01-12.
Who is sponsoring clinical trial NCT01014286?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.